Sequential Inhalational Tobramycin-Colistin-Combination in CF-Patients with Chronic P. Aeruginosa Colonization - an Observational Study

Background/Aims: In cystic fibrosis (CF), chronic microbial lung infections are difficult to treat and cause morbidity and increased mortality. Methods: In a multicentre, open-label, exploratory, non-interventional study, inhaled tobramycin (300 mg twice daily) and colistin (1 million I.U. twice dai...

Full beskrivning

Bibliografiska uppgifter

Huvudupphov:	Joachim Riethmüller, Gloria Herrmann, Ute Graepler-Mainka, Dorothea Hellwig, Hans-Eberhard Heuer, Susanne Heyder, Holger Köster, Birte Kinder, Kristina Kröger, Klaus Paul, Krystyna Poplawska, Volker O. Melichar, Christina Smaczny, Uwe Mellies
Materialtyp:	Artigo
Språk:	Inglês
Utgiven:	Cell Physiol Biochem Press GmbH & Co KG 2016-08-01
Serie:	Cellular Physiology and Biochemistry
Ämnen:	Cystic Fibrosis Lung infection P. Aeruginosa Inhaled tobramycin and colistin
Länkar:	http://www.karger.com/Article/FullText/447821
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!